Plasminogen activator inhibitor-1 enhances radioresistance and aggressiveness of non-small cell lung cancer cells

Acquired resistance of tumor cells during treatment limits the clinical efficacy of radiotherapy. Recent studies to investigate acquired resistance under treatment have focused on intercellular communication because it promotes survival and aggressiveness of tumor cells, causing therapy failure and...

Descripción completa

Detalles Bibliográficos
Autores principales: Kang, JiHoon, Kim, Wanyeon, Kwon, TaeWoo, Youn, HyeSook, Kim, Joong Sun, Youn, BuHyun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5029677/
https://www.ncbi.nlm.nih.gov/pubmed/27004408
http://dx.doi.org/10.18632/oncotarget.8208

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5029677/
https://www.ncbi.nlm.nih.gov/pubmed/27004408
http://dx.doi.org/10.18632/oncotarget.8208

Ejemplares similares